Eptinezumab: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Eptinezumab. Educational only — not medical advice.
Labeled uses
VYEPTI is indicated for the preventive treatment of migraine in adults.
Source: FDA labeling via NIH DailyMed (set 79065861…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.